Related Experiment Video
Updated: Jun 21, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.5K
MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis
Lixian Ding1,2, Mingjun Sun1,2, Yanyan Sun1,2
1Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Cancer Medicine
|July 11, 2024
Summary
Minichromosome maintenance protein 8 (MCM8) is upregulated in gastric cancer (GC), predicting poor prognosis. MCM8, along with RPS15A, drives GC progression by promoting proliferation and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) is a leading cause of cancer death globally.
- Minichromosome maintenance protein 8 (MCM8) plays a role in DNA repair and replication.
- MCM8 exhibits tumor-promoting functions in digestive cancers and is a potential therapeutic target.
Purpose of the Study:
- To investigate the expression and clinicopathological significance of MCM8 in GC.
- To elucidate the functional role of MCM8 in GC progression.
- To identify the molecular targets of MCM8 in GC.
Main Methods:
- Bioinformatic analysis of MCM8 expression and clinical data.
- Immunohistochemistry (IHC) and qRT-PCR for MCM8 detection.
- In vitro assays (cell counting, colony formation, migration, invasion, apoptosis) to assess MCM8 function.
- Gene expression microarrays and phospho-kinase arrays to identify MCM8 targets and signaling pathways.
- In vivo studies using a xenograft mouse model.
Main Results:
- MCM8 was significantly upregulated in GC and correlated with poor prognosis, advanced stage, and lymph node metastasis.
- MCM8 knockdown inhibited GC cell proliferation, migration, and invasion, while promoting apoptosis.
- RPS15A was identified as a direct target of MCM8, and the MCM8/RPS15A complex promoted phosphorylation of P38α, LYN, and p70S6K.
- In vivo, MCM8 knockdown suppressed tumor growth and related signaling pathways.
Conclusions:
- MCM8 acts as an oncogene in GC, predicting unfavorable outcomes.
- The MCM8/RPS15A axis is crucial for GC progression.
- Targeting MCM8 may offer a therapeutic strategy for GC.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K

